 | • レポートコード：QAF27564 • 出版社/出版日：QYResearch / 2021年4月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の抗凝固薬市場について種類別（NOAC、ヘパリン、ワルファリン、その他）、用途別（病院、薬局、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗凝固薬市場の概要 ・世界の主要地域別抗凝固薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の抗凝固薬市場規模2016-2021：種類別（NOAC、ヘパリン、ワルファリン、その他） ・世界の抗凝固薬市場予測2012-2027：種類別（NOAC、ヘパリン、ワルファリン、その他） ・世界の抗凝固薬市場規模2016-2021：用途別（病院、薬局、その他） ・世界の抗凝固薬市場予測2012-2027：用途別（病院、薬局、その他） ・抗凝固薬のアメリカ市場規模と予測2016-2021 ・抗凝固薬のヨーロッパ市場規模と予測2016-2021 ・抗凝固薬の中国市場規模と予測2016-2021 ・抗凝固薬の日本市場規模と予測2016-2021 ・抗凝固薬の東南アジア市場規模と予測2016-2021 ・抗凝固薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bristol-Myers Squibb、Bayer、Pfizer、Johnson & Johnson、Sanofi、Boehringer Ingelheim、Daiichi Sankyo） ・抗凝固薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗凝固薬の市場動向・機会・課題 ・調査の結論 |
Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
Market Analysis and Insights: Global Anticoagulant Drugs Market
The global Anticoagulant Drugs market was valued at US$ 29890 in 2020 and will reach US$ 39590 million by the end of 2027, growing at a CAGR of 4.8% during 2022-2027.
Global Anticoagulant Drugs Scope and Market Size
The global Anticoagulant Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anticoagulant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
NOACs
Heparin
Warfarin
Others
Segment by Application
Hospital
Pharmacy
Others
The Anticoagulant Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Anticoagulant Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo
1 Anticoagulant Drugs Market Overview
1.1 Anticoagulant Drugs Product Scope
1.2 Anticoagulant Drugs Segment by Type
1.2.1 Global Anticoagulant Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 NOACs
1.2.3 Heparin
1.2.4 Warfarin
1.2.5 Others
1.3 Anticoagulant Drugs Segment by Application
1.3.1 Global Anticoagulant Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Anticoagulant Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Anticoagulant Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Anticoagulant Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Anticoagulant Drugs Price Trends (2016-2027)
2 Anticoagulant Drugs Estimates and Forecasts by Region
2.1 Global Anticoagulant Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Anticoagulant Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Anticoagulant Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Anticoagulant Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Anticoagulant Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Anticoagulant Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Anticoagulant Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Anticoagulant Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Anticoagulant Drugs Estimates and Projections (2016-2027)
2.4.3 China Anticoagulant Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Anticoagulant Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Anticoagulant Drugs Estimates and Projections (2016-2027)
2.4.6 India Anticoagulant Drugs Estimates and Projections (2016-2027)
3 Global Anticoagulant Drugs Competition Landscape by Players
3.1 Global Top Anticoagulant Drugs Players by Sales (2016-2021)
3.2 Global Top Anticoagulant Drugs Players by Revenue (2016-2021)
3.3 Global Anticoagulant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulant Drugs as of 2020)
3.4 Global Anticoagulant Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Anticoagulant Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Anticoagulant Drugs Market Size by Type
4.1 Global Anticoagulant Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Anticoagulant Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Anticoagulant Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Anticoagulant Drugs Price by Type (2016-2021)
4.2 Global Anticoagulant Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Anticoagulant Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Anticoagulant Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Anticoagulant Drugs Price Forecast by Type (2022-2027)
5 Global Anticoagulant Drugs Market Size by Application
5.1 Global Anticoagulant Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Anticoagulant Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Anticoagulant Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Anticoagulant Drugs Price by Application (2016-2021)
5.2 Global Anticoagulant Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Anticoagulant Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Anticoagulant Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Anticoagulant Drugs Price Forecast by Application (2022-2027)
6 North America Anticoagulant Drugs Market Facts & Figures
6.1 North America Anticoagulant Drugs Sales by Company
6.1.1 North America Anticoagulant Drugs Sales by Company (2016-2021)
6.1.2 North America Anticoagulant Drugs Revenue by Company (2016-2021)
6.2 North America Anticoagulant Drugs Sales Breakdown by Type
6.2.1 North America Anticoagulant Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Anticoagulant Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Anticoagulant Drugs Sales Breakdown by Application
6.3.1 North America Anticoagulant Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Anticoagulant Drugs Sales Breakdown by Application (2022-2027)
7 Europe Anticoagulant Drugs Market Facts & Figures
7.1 Europe Anticoagulant Drugs Sales by Company
7.1.1 Europe Anticoagulant Drugs Sales by Company (2016-2021)
7.1.2 Europe Anticoagulant Drugs Revenue by Company (2016-2021)
7.2 Europe Anticoagulant Drugs Sales Breakdown by Type
7.2.1 Europe Anticoagulant Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Anticoagulant Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Anticoagulant Drugs Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)
8 China Anticoagulant Drugs Market Facts & Figures
8.1 China Anticoagulant Drugs Sales by Company
8.1.1 China Anticoagulant Drugs Sales by Company (2016-2021)
8.1.2 China Anticoagulant Drugs Revenue by Company (2016-2021)
8.2 China Anticoagulant Drugs Sales Breakdown by Type
8.2.1 China Anticoagulant Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Anticoagulant Drugs Sales Breakdown by Type (2022-2027)
8.3 China Anticoagulant Drugs Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)
9 Japan Anticoagulant Drugs Market Facts & Figures
9.1 Japan Anticoagulant Drugs Sales by Company
9.1.1 Japan Anticoagulant Drugs Sales by Company (2016-2021)
9.1.2 Japan Anticoagulant Drugs Revenue by Company (2016-2021)
9.2 Japan Anticoagulant Drugs Sales Breakdown by Type
9.2.1 Japan Anticoagulant Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Anticoagulant Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Anticoagulant Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Anticoagulant Drugs Market Facts & Figures
10.1 Southeast Asia Anticoagulant Drugs Sales by Company
10.1.1 Southeast Asia Anticoagulant Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Anticoagulant Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Anticoagulant Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Anticoagulant Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Anticoagulant Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Anticoagulant Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Anticoagulant Drugs Market Facts & Figures
11.1 India Anticoagulant Drugs Sales by Company
11.1.1 India Anticoagulant Drugs Sales by Company (2016-2021)
11.1.2 India Anticoagulant Drugs Revenue by Company (2016-2021)
11.2 India Anticoagulant Drugs Sales Breakdown by Type
11.2.1 India Anticoagulant Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Anticoagulant Drugs Sales Breakdown by Type (2022-2027)
11.3 India Anticoagulant Drugs Sales Breakdown by Application
11.3.1 India Anticoagulant Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Anticoagulant Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Anticoagulant Drugs Business
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Corporation Information
12.1.2 Bristol-Myers Squibb Business Overview
12.1.3 Bristol-Myers Squibb Anticoagulant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bristol-Myers Squibb Anticoagulant Drugs Products Offered
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Anticoagulant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Anticoagulant Drugs Products Offered
12.2.5 Bayer Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Anticoagulant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Anticoagulant Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Business Overview
12.4.3 Johnson & Johnson Anticoagulant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson Anticoagulant Drugs Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Business Overview
12.5.3 Sanofi Anticoagulant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sanofi Anticoagulant Drugs Products Offered
12.5.5 Sanofi Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Corporation Information
12.6.2 Boehringer Ingelheim Business Overview
12.6.3 Boehringer Ingelheim Anticoagulant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Boehringer Ingelheim Anticoagulant Drugs Products Offered
12.6.5 Boehringer Ingelheim Recent Development
12.7 Daiichi Sankyo
12.7.1 Daiichi Sankyo Corporation Information
12.7.2 Daiichi Sankyo Business Overview
12.7.3 Daiichi Sankyo Anticoagulant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Daiichi Sankyo Anticoagulant Drugs Products Offered
12.7.5 Daiichi Sankyo Recent Development
…
13 Anticoagulant Drugs Manufacturing Cost Analysis
13.1 Anticoagulant Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anticoagulant Drugs
13.4 Anticoagulant Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anticoagulant Drugs Distributors List
14.3 Anticoagulant Drugs Customers
15 Market Dynamics
15.1 Anticoagulant Drugs Market Trends
15.2 Anticoagulant Drugs Drivers
15.3 Anticoagulant Drugs Market Challenges
15.4 Anticoagulant Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anticoagulant Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Anticoagulant Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Anticoagulant Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Anticoagulant Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Anticoagulant Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Anticoagulant Drugs Revenue Share by Region (2016-2021)
Table 8. Global Anticoagulant Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Anticoagulant Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Anticoagulant Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Anticoagulant Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Anticoagulant Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Anticoagulant Drugs Sales Share by Company (2016-2021)
Table 14. Global Anticoagulant Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Anticoagulant Drugs Revenue Share by Company (2016-2021)
Table 16. Global Anticoagulant Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulant Drugs as of 2020)
Table 17. Global Anticoagulant Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Anticoagulant Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Anticoagulant Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Anticoagulant Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Anticoagulant Drugs Sales Share by Type (2016-2021)
Table 23. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Anticoagulant Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Anticoagulant Drugs Sales Share by Type (2022-2027)
Table 26. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Anticoagulant Drugs Revenue Share by Type (2022-2027)
Table 28. Global Anticoagulant Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Anticoagulant Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Anticoagulant Drugs Sales Share by Application (2016-2021)
Table 31. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Anticoagulant Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Anticoagulant Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Anticoagulant Drugs Sales Share by Application (2022-2027)
Table 35. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Anticoagulant Drugs Revenue Share by Application (2022-2027)
Table 37. Global Anticoagulant Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Anticoagulant Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Anticoagulant Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Anticoagulant Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Anticoagulant Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Anticoagulant Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Anticoagulant Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Anticoagulant Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Anticoagulant Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Anticoagulant Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Anticoagulant Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Anticoagulant Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Anticoagulant Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Anticoagulant Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Anticoagulant Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Anticoagulant Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Anticoagulant Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Anticoagulant Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Anticoagulant Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Anticoagulant Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Anticoagulant Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Anticoagulant Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Anticoagulant Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Anticoagulant Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Anticoagulant Drugs Sales Market Share by Application (2022-2027)
Table 62. China Anticoagulant Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Anticoagulant Drugs Sales Market Share by Company (2016-2021)
Table 64. China Anticoagulant Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Anticoagulant Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Anticoagulant Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Anticoagulant Drugs Sales Market Share by Type (2016-2021)
Table 68. China Anticoagulant Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Anticoagulant Drugs Sales Market Share by Type (2022-2027)
Table 70. China Anticoagulant Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Anticoagulant Drugs Sales Market Share by Application (2016-2021)
Table 72. China Anticoagulant Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Anticoagulant Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Anticoagulant Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Anticoagulant Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Anticoagulant Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Anticoagulant Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Anticoagulant Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Anticoagulant Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Anticoagulant Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Anticoagulant Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Anticoagulant Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Anticoagulant Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Anticoagulant Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Anticoagulant Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Anticoagulant Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Anticoagulant Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Anticoagulant Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Anticoagulant Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Anticoagulant Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Anticoagulant Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Anticoagulant Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Anticoagulant Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Anticoagulant Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Anticoagulant Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Anticoagulant Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Anticoagulant Drugs Sales Market Share by Application (2022-2027)
Table 98. India Anticoagulant Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Anticoagulant Drugs Sales Market Share by Company (2016-2021)
Table 100. India Anticoagulant Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Anticoagulant Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Anticoagulant Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Anticoagulant Drugs Sales Market Share by Type (2016-2021)
Table 104. India Anticoagulant Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Anticoagulant Drugs Sales Market Share by Type (2022-2027)
Table 106. India Anticoagulant Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Anticoagulant Drugs Sales Market Share by Application (2016-2021)
Table 108. India Anticoagulant Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Anticoagulant Drugs Sales Market Share by Application (2022-2027)
Table 110. Bristol-Myers Squibb Corporation Information
Table 111. Bristol-Myers Squibb Description and Business Overview
Table 112. Bristol-Myers Squibb Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Bristol-Myers Squibb Anticoagulant Drugs Product
Table 114. Bristol-Myers Squibb Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Bayer Anticoagulant Drugs Product
Table 119. Bayer Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Pfizer Anticoagulant Drugs Product
Table 124. Pfizer Recent Development
Table 125. Johnson & Johnson Corporation Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Johnson & Johnson Anticoagulant Drugs Product
Table 129. Johnson & Johnson Recent Development
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Sanofi Anticoagulant Drugs Product
Table 134. Sanofi Recent Development
Table 135. Boehringer Ingelheim Corporation Information
Table 136. Boehringer Ingelheim Description and Business Overview
Table 137. Boehringer Ingelheim Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Boehringer Ingelheim Anticoagulant Drugs Product
Table 139. Boehringer Ingelheim Recent Development
Table 140. Daiichi Sankyo Corporation Information
Table 141. Daiichi Sankyo Description and Business Overview
Table 142. Daiichi Sankyo Anticoagulant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Daiichi Sankyo Anticoagulant Drugs Product
Table 144. Daiichi Sankyo Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Anticoagulant Drugs Distributors List
Table 148. Anticoagulant Drugs Customers List
Table 149. Anticoagulant Drugs Market Trends
Table 150. Anticoagulant Drugs Market Drivers
Table 151. Anticoagulant Drugs Market Challenges
Table 152. Anticoagulant Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticoagulant Drugs Product Picture
Figure 2. Global Anticoagulant Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anticoagulant Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Others Examples
Figure 9. Global Anticoagulant Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anticoagulant Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Anticoagulant Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Anticoagulant Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Anticoagulant Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Anticoagulant Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Anticoagulant Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Anticoagulant Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Anticoagulant Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Anticoagulant Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Anticoagulant Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Anticoagulant Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Anticoagulant Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Anticoagulant Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Anticoagulant Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Anticoagulant Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Anticoagulant Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Anticoagulant Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Anticoagulant Drugs Players Market Share by Revenue in Anticoagulant Drugs: 2016 & 2020
Figure 28. Anticoagulant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Anticoagulant Drugs Revenue Share by Type (2016-2021)
Figure 30. Global Anticoagulant Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Anticoagulant Drugs Revenue Share by Application (2016-2021)
Figure 32. Global Anticoagulant Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Anticoagulant Drugs Sales Market Share by Type in 2020
Figure 34. North America Anticoagulant Drugs Sales Market Share by Application in 2020
Figure 35. Europe Anticoagulant Drugs Sales Market Share by Type in 2020
Figure 36. Europe Anticoagulant Drugs Sales Market Share by Application in 2020
Figure 37. China Anticoagulant Drugs Sales Market Share by Type in 2020
Figure 38. China Anticoagulant Drugs Sales Market Share by Application in 2020
Figure 39. Japan Anticoagulant Drugs Sales Market Share by Type in 2020
Figure 40. Japan Anticoagulant Drugs Sales Market Share by Application in 2020
Figure 41. Southeast Asia Anticoagulant Drugs Sales Market Share by Type in 2020
Figure 42. Southeast Asia Anticoagulant Drugs Sales Market Share by Application in 2020
Figure 43. India Anticoagulant Drugs Sales Market Share by Type in 2020
Figure 44. India Anticoagulant Drugs Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Anticoagulant Drugs
Figure 47. Manufacturing Process Analysis of Anticoagulant Drugs
Figure 48. Anticoagulant Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の抗凝固治療市場規模・現状・予測（2021年-2027年） Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. Market Analysis and Insights: Global Anticoagulant Treatment Market The global Anticoagulant Treatment market size is projected to reach US$ XX …- 世界の抗凝固治療薬モニタリングアッセイキット市場規模・現状・予測（2021年-2027年） Anticoagulant therapeutic drugs prevent or reduce blood coagulation and delay clotting time which can block arteries, veins or the valves of the heart. Market Analysis and Insights: Global Anticoagulant Therapeutic Drug Monitoring Assay Kit Market The global Anticoagulant Therapeutic Drug Monitoring…
- 経口抗凝固薬のグローバル市場調査 2019年 The global Oral Anticoagulant market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Oral Anticoagulant volume and value at global level, regional level and company level. From a global perspective, this r…
- 世界の直接経口抗凝固薬産業調査2019-2025 Direct Oral Anticoagulants are rapid and short acting agents which have relatively low bleeding risks and overall safety. Direct oral anticoagulants are alternative choice for blood clot treatment in selected patients.In 2018, the global Direct Oral Anticoagulant market size was xx million US$ and i…
- 世界の直接経口抗凝固薬産業調査2019-2025 Direct Oral Anticoagulants are rapid and short acting agents which have relatively low bleeding risks and overall safety. Direct oral anticoagulants are alternative choice for blood clot treatment in selected patients.In 2018, the global Direct Oral Anticoagulant market size was xx million US$ and i…